Press Release R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis R1 Therapeutics · Jul 21
Press Release Aebi Schmidt Group declares quarterly dividend of $0.025 per share and will announce second quarter 2026 earnings on August 13, 2026 Aebi Schmidt Group / Aebi Schmidt Holding AG · Jul 21
Press Release Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice Aclarion, Inc. · Jul 21
Press Release Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026 Pasithea · Jul 21
Press Release Omai Gold to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on July 23rd Virtual Investor Conferences · Jul 21
Press Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Vicor Corporation · Jul 21
Press Release Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T Tempest Therapeutics · Jul 21
Press Release CEI Expands Executive Leadership to Accelerate the Next Generation of AI-Native Enterprise Transformation CEI · Jul 21
Press Release Talisker Reports Mustang Underground Face Sample Results and Defines a 127 metre Strike Length High-grade Shoot Averaging 22 g/t on the 1045 Level including 610 g/t over 0.51 of a metre Talisker Resources Ltd. · Jul 21